Boehringer Ingelheim Receives Perfect Rating on Human Rights Campaign Foundation's Corporate Equality Index

November 20, 2014

Boehringer Ingelheim announced today that it received a perfect score of 100 percent on the 2015 Corporate Equality Index.

Company also recognized this week on Hispanic Network Magazine’s Best of the Best list, and recently by DiversityInc, Science magazine and Working Mother

Ridgefield, Conn., November 20, 2014 — Boehringer Ingelheim announced today that it received a perfect score of 100 percent on the 2015 Corporate Equality Index (CEI). Administered by the Human Rights Campaign Foundation, this index is a national benchmarking report on corporate policies and practices related to lesbian, gay, bisexual and transgender (LGBT) employees. This is the seventh time the company has received a perfect score and been designated as a “Best Place to Work for LGBT Equality.”

“Diversity in the workplace is a crucial facet of our corporate culture, and we are proud to be recognized for our commitment of promoting an inclusive working environment,” said Nancy Di Dia, Chief Diversity and Inclusion Officer, Boehringer Ingelheim. “It is important that we continue to place great value on recruiting and retaining a diverse and talented employee base, so we can continue to move our business forward and serve our broad patient population.”

Since 2002, the CEI has become an important tool for businesses in the U.S. regarding LGBT equality in the workplace. The 2015 CEI rated 972 businesses and evaluated LGBT-related practices, including non-discrimination workplace protections, domestic partner benefits, transgender-inclusive health care benefits, competency programs, and public engagement with the LGBT community. Boehringer Ingelheim’s efforts in satisfying CEI’s criteria resulted in a 100 percent score. The company is among only 364 major U.S. businesses that earned top marks this year.

In addition to this recognition, Boehringer Ingelheim was named this week to Hispanic Network Magazine’s Best of the Best list as one of the Top Disability-Friendly Employers. The company has also recently received other workplace accolades, including being recognized on the following lists:

  • DiversityInc’s 25 Noteworthy Companies and Top 10 Companies for People with Disabilities;
  • Science magazine’s Top Employers; and
  • Working Mother’s 100 Best Companies.

For more information on the 2015 CEI or to download the report, visit www.hrc.org/cei.

About the Human Rights Campaign

The Human Rights Campaign is America's largest civil rights organization working to achieve lesbian, gay, bisexual and transgender equality. By inspiring and engaging all Americans, HRC strives to end discrimination against LGBT citizens and realize a nation that achieves fundamental fairness and equality for all.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, Conn., is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.

In 2013, Boehringer Ingelheim achieved net sales of about $18.7 billion (14.1 billion euro). R&D expenditure in the Prescription Medicines business corresponds to 19.5% of its net sales.

For more information please visit http://www.us.boehringer-ingelheim.com